Utilizing bidirectional Mendelian randomization to uncover the relationship between infectious diseases and primary biliary cholangitis
EBNA-1 antibodies potentially exerting a protective effect and ZEBRA antibodies acting as a risk factor plays a dual role in the pathogenesis of PBC, highlighting the complex host–pathogen interactions that require further in-depth study.